232 related articles for article (PubMed ID: 17418236)
1. Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells.
Raska M; Moldoveanu Z; Suzuki H; Brown R; Kulhavy R; Andrasi J; Hall S; Vu HL; Carlsson F; Lindahl G; Tomana M; Julian BA; Wyatt RJ; Mestecky J; Novak J
J Mol Biol; 2007 May; 369(1):69-78. PubMed ID: 17418236
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic sialylation of IgA1 O-glycans: implications for studies of IgA nephropathy.
Takahashi K; Raska M; Stuchlova Horynova M; Hall SD; Poulsen K; Kilian M; Hiki Y; Yuzawa Y; Moldoveanu Z; Julian BA; Renfrow MB; Novak J
PLoS One; 2014; 9(2):e99026. PubMed ID: 24918438
[TBL] [Abstract][Full Text] [Related]
3. N-acetylgalactosaminide α2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy.
Stuchlova Horynova M; Vrablikova A; Stewart TJ; Takahashi K; Czernekova L; Yamada K; Suzuki H; Julian BA; Renfrow MB; Novak J; Raska M
Nephrol Dial Transplant; 2015 Feb; 30(2):234-8. PubMed ID: 25281698
[TBL] [Abstract][Full Text] [Related]
4. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Vu HL; Novak L; Julian BA; Tomana M; Wyatt RJ; Edberg JC; Alarcón GS; Kimberly RP; Tomino Y; Mestecky J; Novak J
J Clin Invest; 2008 Feb; 118(2):629-39. PubMed ID: 18172551
[TBL] [Abstract][Full Text] [Related]
5. Activity of alpha2,6-sialyltransferase and its gene expression in peripheral B lymphocytes in patients with IgA nephropathy.
Ding JX; Xu LX; Zhu L; Lv JC; Zhao MH; Zhang H; Wang HY
Scand J Immunol; 2009 Feb; 69(2):174-80. PubMed ID: 19170967
[TBL] [Abstract][Full Text] [Related]
6. GalNAc-T14 may Contribute to Production of Galactose-Deficient Immunoglobulin A1, the Main Autoantigen in IgA Nephropathy.
Jemelkova J; Stuchlova Horynova M; Kosztyu P; Zachova K; Zadrazil J; Galuszkova D; Takahashi K; Novak J; Raska M
Kidney Int Rep; 2023 May; 8(5):1068-1075. PubMed ID: 37180502
[TBL] [Abstract][Full Text] [Related]
7. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.
Xu LX; Yan Y; Zhang JJ; Zhang Y; Zhao MH
Clin Exp Immunol; 2005 Dec; 142(3):569-75. PubMed ID: 16297170
[TBL] [Abstract][Full Text] [Related]
8. Defective immunoglobulin A (IgA) glycosylation and IgA deposits in patients with IgA nephropathy.
Kolka R; Valdimarsson H; Bodvarsson M; Hardarson S; Jonsson T
APMIS; 2013 Sep; 121(9):890-7. PubMed ID: 23398317
[TBL] [Abstract][Full Text] [Related]
9. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.
Suzuki H; Raska M; Yamada K; Moldoveanu Z; Julian BA; Wyatt RJ; Tomino Y; Gharavi AG; Novak J
J Biol Chem; 2014 Feb; 289(8):5330-9. PubMed ID: 24398680
[TBL] [Abstract][Full Text] [Related]
10. Reversible sialylation: synthesis of cytidine 5'-monophospho-N-acetylneuraminic acid from cytidine 5'-monophosphate with alpha2,3-sialyl O-glycan-, glycolipid-, and macromolecule-based donors yields diverse sialylated products.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Matta KL; Neelamegham S
Biochemistry; 2008 Jan; 47(1):320-30. PubMed ID: 18067323
[TBL] [Abstract][Full Text] [Related]
11. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
Gomes MM; Suzuki H; Brooks MT; Tomana M; Moldoveanu Z; Mestecky J; Julian BA; Novak J; Herr AB
Biochemistry; 2010 Jul; 49(27):5671-82. PubMed ID: 20507092
[TBL] [Abstract][Full Text] [Related]
12. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: An integrated analysis of the transcriptome.
Liu Y; Wang F; Zhang Y; Jia J; Yan T
J Cell Mol Med; 2020 Sep; 24(18):10493-10500. PubMed ID: 32677771
[TBL] [Abstract][Full Text] [Related]
13. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
Suzuki H; Moldoveanu Z; Hall S; Brown R; Julian BA; Wyatt RJ; Tomana M; Tomino Y; Novak J; Mestecky J
Contrib Nephrol; 2007; 157():129-33. PubMed ID: 17495450
[TBL] [Abstract][Full Text] [Related]
14. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy.
Xu LX; Zhao MH
Kidney Int; 2005 Jul; 68(1):167-72. PubMed ID: 15954905
[TBL] [Abstract][Full Text] [Related]
15. Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?
Leung JC; Poon PY; Lai KN
J Lab Clin Med; 1999 Feb; 133(2):152-60. PubMed ID: 9989767
[TBL] [Abstract][Full Text] [Related]
16. Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins.
Moore JS; Kulhavy R; Tomana M; Moldoveanu Z; Suzuki H; Brown R; Hall S; Kilian M; Poulsen K; Mestecky J; Julian BA; Novak J
Mol Immunol; 2007 Apr; 44(10):2598-604. PubMed ID: 17275907
[TBL] [Abstract][Full Text] [Related]
17. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy.
Leung JC; Tang SC; Chan DT; Lui SL; Lai KN
J Clin Lab Anal; 2002; 16(1):11-9. PubMed ID: 11835525
[TBL] [Abstract][Full Text] [Related]
18. Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individuals.
Lehoux S; Mi R; Aryal RP; Wang Y; Schjoldager KT; Clausen H; van Die I; Han Y; Chapman AB; Cummings RD; Ju T
Mol Cell Proteomics; 2014 Nov; 13(11):3097-113. PubMed ID: 25071157
[TBL] [Abstract][Full Text] [Related]
19. Loss of the Golgi Matrix Protein 130 Cause Aberrant IgA1 Glycosylation in IgA Nephropathy.
Wang C; Ye M; Zhao Q; Xia M; Liu D; He L; Chen G; Peng Y; Liu H
Am J Nephrol; 2019; 49(4):307-316. PubMed ID: 30917363
[TBL] [Abstract][Full Text] [Related]
20. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
